Professional Documents
Culture Documents
CAM Chart Rev Feb 2022
CAM Chart Rev Feb 2022
Medicine
Product Action Dosage Formulation Risks/contraindications Notes
ALPHA-CASOZEPINE anxiety 15.0 mg/kg (or oral; may be in no reported risks or tryptic
reduction higher up to 25.0 combination with contraindications hydrolysate of
(benzodiazepine mg/kg) daily, other products or milk protein
type effect) beginning 1-2 diets
days in advance
of need
L-THEANINE fear and anxiety 2.5-5.0 mg/kg PO oral no reported risks or amino acid
reduction twice daily, 2-4 contraindications found in green
weeks to effect tea leaves
Acute dosing,
2.5-5.0 mg PO 12
hours prior and
again 2 hours
prior to a fearful
event
L-TRYPTOPHAN anxiety 10-15 mg/kg per oral may increase serotonin; most effective
reduction; day therefore use cautiously with when combined
serotonin drugs that increase serotonin with a low
precursor may protein diet;
increase may take
serotonin levels several weeks
to see effects
PHEROMONE appeasing and N/A spray, wipes, no reported risks or effects are
THERAPY calming diffusers – dogs contraindications species specific
and cats - products do
collars (dogs only) not have effect
on all animals
The AVMA Policy on Owner Consent states that veterinarians or staff should provide sufficient information in a form and manner that
enables owners or their authorized agents to make appropriate decisions when choosing the veterinary care provided. An assessment of
risks and benefits of recommended treatments should be provided. In response owners or their authorized agents should indicate:
The consent can be verbal or written and should be documented in the medical record by the veterinarian or staff member.
Taken from the AVMA Policy on Owner Consent in Veterinary Medicine. You should review the complete policy here:
https://www.avma.org/KB/Policies/Pages/Owner-Consent-in-Veterinary-Medicine.aspx